Titan Pharmaceuticals (TTNP) to Explore Strategic Alternatives

Titan Pharmaceuticals (TTNP) announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder value.

Update(s):

August 16, 2022: Lazar was appointed interim Chairman and Chief Executive Officer, with a mandate to lead Titan’s continuing review of strategic alternatives.